# Duan Xufang

> Duan Xufang is a Series A investor at Qianhai Fund of Funds backing Medical and Health Care. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Qianhai Fund of Funds](https://shizune.co/investors/profile/qianhai-fund-of-funds)
- Total investments: 3
- Last investment: Nov 2024
- Lead investor: 100%
- Last updated: Aug 2026

Duan Xufang is a Series A investor at Qianhai Fund of Funds focused on Medical and Health Care. is partner of Qianhai Fund of Funds.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 2 | 67% |
| Health Care | 2 | 67% |
| Biotechnology | 2 | 67% |
| Robotics | 1 | 33% |
| Biopharma | 1 | 33% |

7 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 33% |
| Series B | 1 | 33% |
| Private Equity | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Aoda Zhisheng | Aoda Zhisheng provides clinical robot systems, technology, and smart medical comprehensive solutions. |  | Series A | Nov 01, 2024 |  |
| Hebei Senlang Biotechnology | Hebei Senlang Biotechnology is focused on the treatment of immune cells new technology development and application of high-tech enterprises.The company has the CAR-T research base (Senrang CAR-T Research Center) in North China, and has formed a high-barrier technology platform such as innovative CAR structural design, virus and cell culture , whichcan take into account technical research and development, hospital clinical application Provide high-quality and effective cellular immunotherapy support for hematological tumors, solid tumors and other tumor diseases, immune system diseases and other patients. | $29.6M | Private Equity | May 18, 2022 |  |
| Resproly | Resproly is a research and development, production and sales of formula and equipment for respiratory inhalation. An integrated enterprise that focuses on multiple clinically demanding treatment areas such as Asthma, Chronic Obstructive Pulmonary Disease (COPD), Diabetes, and Parkinson's Disease. |  | Series B | Apr 30, 2022 |  |

3 of 3 investments shown.

## Co-investors
- [BioVenture](https://shizune.co/investors/profile/bioventure) — VC Fund, 1 deal together
- [Fuho Capital](https://shizune.co/investors/profile/fuho-capital) — VC Fund, 1 deal together

## About Qianhai Fund of Funds

VC Fund · Shanzhen, China

Qianhai Fund of Funds is a fund management company that markets qualified investors in the private equity investment industry. Qianhai Fund of Funds comes from four types of LP's such as local governments, well-known companies, insurance financial institutions, and a number of listed companies and well-known corporate controllers. The fundmanagement party introduced at the press conference that the Qianhai Fund of Funds' overall investment strategy pursues low-risk, medium-to-high-yield, mainly based on high-quality venture capital, and private equity investment funds, supplemented by direct investment and short-term investment.Qianhai Fund of Funds was founded on 2015 and is headquartered in Shenzhen, China.

5 contacts available at Qianhai Fund of Funds.

| Name | Title | Profile |
| --- | --- | --- |
| Ang Gao | Managing Partner | https://shizune.co/investors/profile/gao-gao-b681 |
| Duan Xufang | Partner | https://shizune.co/investors/profile/duan-xufang |
| Haitao Yan | Chief Executive Partner | https://shizune.co/investors/profile/haitao-yan |
| Hugo Shong | Joint Partner | https://shizune.co/investors/profile/hugo-shong |
| Li Peng | Managing Director | https://shizune.co/investors/profile/li-peng-e956 |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Duan Xufang invest in?

Duan Xufang invests primarily in Medical, Health Care and Biotechnology startups, most often at Series A and Series B stage. Most of the 3 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Duan Xufang last invest?

The most recent investment recorded for Duan Xufang closed in Nov 2024. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co